Zimmer Biomet Holdings, Inc. 11,027,558 Shares Common Stock ($0.01 par value) Underwriting AgreementGoldman Sachs Group Inc • February 10th, 2016 • Security brokers, dealers & flotation companies • New York
Company FiledFebruary 10th, 2016 Industry JurisdictionThe persons named in Schedule II hereto (the “Selling Stockholders”) propose to sell to Barclays Capital Inc. (the “Underwriter”) 11,027,558 shares of common stock, $0.01 par value (“Common Stock”), of Zimmer Biomet Holdings, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), as set forth in Schedule II hereto (said shares to be sold by the Selling Stockholders being hereinafter called the “Securities”). Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the Exchange Act on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the R
JOINT FILING AGREEMENTJoint Filing Agreement • February 10th, 2016 • Goldman Sachs Group Inc • Security brokers, dealers & flotation companies
Contract Type FiledFebruary 10th, 2016 Company IndustryIn accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Zimmer Biotech Holdings, Inc., and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.